|
|
||||||||
Journal of Lipid Research, Vol. 43, 1283-1292, August 2002
Copyright © 2002 by Lipid Research, Inc.


* Baker Medical Research Institute, P.O. Box 6492, St. Kilda Road Central, Melbourne, Victoria, 8008, Australia
Department of Internal Medicine, Fukuoka University, School of Medicine, 45-1, 7-chome Nanakuma, Jonan-ku, Fukuoka, 814-80, Japan
1 To whom correspondence should be addressed. e-mail: dmitri.sviridov{at}baker.edu.au
Five mutants of apolipoprotein A-I (apoA-I), apoA-I(
6373), apoA-I(
140150), apoA-I(6373@140150), apoA-I(R149V), and apoA-I(P143A) were compared with human plasma apoA-I for their ability to promote cholesterol and phospholipid efflux from HepG2 cells. A significantly lower capacity to promote cholesterol and phospholipid efflux was observed with lipid-free apoA-I(
6373), while mutations apoA-I(
140150) and apoA-I(P143A) affected phospholipid efflux only. When added as apoA-I/palmitoyloleoyl phosphatidylcholine (POPC) complex, mutations apoA-I(6373@140150) and apoA-I(
140150) affected cholesterol efflux. None of the mutations affected
-helicity of the lipid-free mutants or their self-association. Five natural mutations of apoA-I, apoA-I(A95D), apoA-I (Y100H), apoA-I(E110K), apoA-I(V156E), and apoA-I (H162Q) were studied for their ability to bind lipids and promote cholesterol efflux. None of the mutations affected lipid-binding properties, cholesterol efflux, or
-helicity of lipid-free mutants. Two mutations affected self-association of apoA-I: apoA-I(A95D) was more prone to self-association, while apoA-I(E100H) did not self-associate.
The following conclusions could be made from the combined data: i) regions 210243 and 63100 are the lipid-binding sites of apoA-I and are also required for the efflux of lipids to lipid-free apoA-I, suggesting that initial lipidation of apoA-I is rate limiting in efflux; ii) in addition to the lipid-binding regions, the central region is important for cholesterol efflux to lipidated apoA-I, suggesting its possible involvement in interaction with cells.
Abbreviations: apoA-I, apolipoprotein A-I; DMPC, dimyristoyl phosphatidylcholine; POPC, palmitoyloleoyl phosphatidylcholine; rHDL, reconstituted HDL
Supplementary key words apolipoprotein A-I high density lipoprotein cholesterol efflux reverse cholesterol transport atherosclerosis thin-layer chromatography
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. D. Wool, C. A. Reardon, and G. S. Getz Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties J. Lipid Res., June 1, 2008; 49(6): 1268 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Escher, A. Hoang, S. Georges, U. Tchoua, A. El-Osta, Z. Krozowski, and D. Sviridov Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages J. Lipid Res., February 1, 2005; 46(2): 356 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sviridov, B. Kingwell, A. Hoang, A. Dart, and P. Nestel Single session exercise stimulates formation of pre{beta}1-HDL in leg muscle J. Lipid Res., March 1, 2003; 44(3): 522 - 526. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |